Amgen clotting drug gets FDA nod

Now it's time for the press release: The FDA approved Amgen's Nplate drug to treat a rare blood-clotting disorder that causes the body to attack its own platelets. Last month, Amgen mistakenly announced that Nplate had won the FDA nod, and had to retract the press release. This time, though, it's for real. Report